Crinetics Pharmaceuticals · 10 hours ago
Associate Director, Drug Product Development
Crinetics Pharmaceuticals is a pharmaceutical company based in San Diego, California, developing much-needed therapies for people with endocrine diseases and endocrine-related tumors. The Associate Director of Drug Product Development will manage activities related to preformulation, biopharmaceutics, and formulation development from Phase 1 to commercial launch, playing a crucial role in the development of therapeutics for rare endocrine disorders.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Integrate biopharmaceutics principles to guide drug product design and development, ensuring clinically meaningful formulation strategies
Design and develop formulation and processes to enable clinical studies with the desired performance
In collaboration with DMPK and Clinical Pharmacology, develop and apply advanced modeling-informed strategies (e.g., PBPK) to predict drug dissolution, absorption, bioavailability, enabling formulation optimization, bridging decisions, and risk mitigation
Design and execute experiments for development of rational, scientifically sound, phase appropriate formulations and manufacturing processes including biorelevant conditions to simulate in vivo performance
Utilize software tools such as GastroPlus to model gastrointestinal physiology and inform formulation decisions
Apply deep understanding of physiological factors (e.g., GI pH, transit times, regional absorption) to interpret human and animal clinical data, linking dissolution behavior to in vivo drug performance and guiding formulation refinement
Contribute biopharmaceutics expertise to regulatory submissions, including IVIVC (In Vitro–In Vivo Correlation) and MIDD (Model-Informed Drug Development)
Stay current with advancements in predictive modeling, dissolution testing methodologies, and regulatory requirements
Plan, direct, and oversee formulation, process development, manufacturing, and packaging activities at contract development and manufacturing organizations (CMOs)
Evaluate and select external partners for drug product development and manufacturing
Prepare Drug Product development and manufacturing timelines and set clear deliverables for projects
Prepare and review request of proposal (RFPs), statements of work (SOWs), and associated budgets
Prepare and review regulatory filings (IBs, INDs, IMPDs, NDAs, briefing packages)
Author and review SOPs, technical reports, specifications, CAPAs, change controls, investigations, and deviations to ensure compliance with cGMP and company standards
Qualification
Required
A PhD in Pharmacokinetics, Pharmaceutical Science, or a related field with at least 7 years of related technical experience in the small molecule biopharmaceutical industry
Experience supporting regulatory submissions with biopharmaceutics expertise
Expertise in PBPK modeling and pharmacokinetics, with proficiency in software tools such as GastroPlus, Phoenix WinNonlin, and Simcyp
Strong knowledge of dissolution testing methodologies and ability to design experiments with accurate testing conditions
Experience in applying biopharmaceutics principles to late-stage drug development and formulation optimization
Familiarity with FDA, EMA, and ICH guidelines related to biopharmaceutics and predictive modeling
Lead work experience in drug product development and clinical manufacturing for small molecules
Excellent analytical, problem-solving, and communication skills
Preferred
Understanding of cGMP requirements and ICH and regulatory guidance is preferred
Benefits
Discretionary annual target bonus
Stock options
ESPP
401k match
Top-notch health insurance plans for employees (and their families) to include medical, dental, vision and basic life insurance
20 days of PTO
10 paid holidays
Winter company shutdown
Company
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.
Funding
Current Stage
Public CompanyTotal Funding
$2BKey Investors
Frazier Healthcare PartnersNational Institutes of HealthPerceptive Advisors
2026-01-07Post Ipo Equity· $349.22M
2024-10-08Post Ipo Equity· $500M
2024-02-28Post Ipo Equity· $350M
Recent News
2026-01-07
2026-01-07
Company data provided by crunchbase